摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(N-Piperiddino)-9H-purin | 17587-92-7

中文名称
——
中文别名
——
英文名称
2-(N-Piperiddino)-9H-purin
英文别名
2-Piperidino-purin;2-piperidin-1-yl-7(9)H-purine;Purine, 2-piperidino-;2-piperidin-1-yl-7H-purine
2-(N-Piperiddino)-9H-purin化学式
CAS
17587-92-7
化学式
C10H13N5
mdl
——
分子量
203.247
InChiKey
MZMXZDWSVQWARY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    57.7
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • [EN] DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS<br/>[FR] INHIBITEURS DE DIACYLGLYCÉROL ACYLTRANSFÉRASE 2
    申请人:PFIZER
    公开号:WO2013150416A1
    公开(公告)日:2013-10-10
    Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H- imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
    这里描述了抑制二酰基甘油酰基转移酶2(DGAT2)活性的嘌呤生物,即式I的3H-咪唑并[4,5-b]嘧啶1H-咪唑并[4,5-d]吡嗪,以及它们在治疗相关动物疾病中的用途。
  • DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
    申请人:Pfizer Inc.
    公开号:US20150087585A1
    公开(公告)日:2015-03-26
    Derivatives of purine, 3H-imidazo[4,5-b]pyrimidine and 1H-imidazo[4,5-d]pyrazine of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
    本文描述了嘌呤的衍生物,Formula I的3H-咪唑并[4,5-b]嘧啶1H-咪唑并[4,5-d]吡嗪,它们抑制二酰基甘油酰基转移酶2(DGAT2)的活性,并在动物治疗相关疾病中的用途。
  • HETEROCYCLIC-IMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
    申请人:SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY CO., LTD
    公开号:US20180111927A1
    公开(公告)日:2018-04-26
    The present invention relates to heterocyclic-imidazole derivatives, a preparation method therefor, and a medical use thereof, and particularly to new heterocyclic-imidazole derivatives as represented by general formula (I), a preparation method therefor, pharmaceutical compositions comprising same, and a use thereof as a therapeutic agent, particularly as a poly(ADP-ribose)polymerase (PARP) inhibitor.
  • US9296745B2
    申请人:——
    公开号:US9296745B2
    公开(公告)日:2016-03-29
查看更多